Loading provider…
Loading provider…
Pulmonary Disease Physician in Cleveland, OH
NPI: 1154385516Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get DO Daniel's Phone Numberphone_androidMobile
Get DO Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease

OH State License
2000 - 2027
Cleveland Clinic Foundation
Fellowship • Pulmonary Disease and Critical Care Medicine
2000 - 2003
Residency • Internal Medicine
1997 - 2000
Heritage College of Osteopathic Medicine
ohio.edu
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 29 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 17 | 18 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 13 | 16 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 13 | 24 |
Authors: Robert Baughman, Sivagini Ganesh, Oksana Shlobin, Rohit Gupta, Francis Cordova, Mary Scholand, Joseph Barney
Journal: Pulm Circ
Publication Date: 2023-10-11
EBUS-TBNA for the diagnosis of sarcoidosis: is it the only game in town?
Authors: Culver, Daniel A, Costabel, Ulrich
Journal: J Bronchology Interv Pulmonol
What is sarcoidosis
Authors: Daniel A. Culver
Publication Date: 2013-09
Lead Sponsor: University of Cincinnati
Collaborators: Albany Medical College, Foundation for Sarcoidosis Research
Intervention / Treatment: DIAGNOSTIC_TEST: Quality of Life
Lead Sponsor: The Cleveland Clinic
Collaborators: Mallinckrodt
Intervention / Treatment: DRUG: Repository Corticotropin Injection, DRUG: Repository Corticotropin Injection -Treatment Extension
Lead Sponsor: Vanderbilt University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: Placebo, DRUG: Levofloxacin, DRUG: Azithromycin, DRUG: Rifampin, DRUG: Ethambutol